Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit

Clinical Kidney Journal

Volumn 8, Issue 2, 2015, Pages 199-201

  Claisse, Guillaume ^a   Delavenne, Xavier ^a   Masson, Ingrid ^a   Maillard, Nicolas ^a   Alamartine, Eric ^a   Mariat, Christophe ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Dabigatran overexposure; Haemodiafiltration; Haemorrhagic shock; Intensive care

Indexed keywords

ADRENALIN; CREATININE; DABIGATRAN; HEMOGLOBIN; OMEPRAZOLE; PROTHROMBIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS HEMODIAFILTRATION; CRITICALLY ILL PATIENT; DIALYSIS CATHETER; DROWSINESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INTOXICATION; DRUG OVERDOSE; EPIGASTRIC PAIN; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL ENDOSCOPY; GLASGOW COMA SCALE; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC SHOCK; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; STOMACH ULCER; SUBDURAL HEMATOMA; TACHYCARDIA;

EID: 84942084829     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfv001     Document Type: Article

References (18)

1. Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151
2. Stangier J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet 2008; 47: 285-295
3. Stangier J, Clemens A. Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor. Clin Appl Thromb Hemost 2009; 15(Suppl 1): S9-16
4. Liensenfeld K-H, Lehr T, Dansirikul C et al. Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial. J Thromb Haemost 2011; 9: 2168-2175
5. Ganetsky M, Babu KM, Salhanick SD et al. Dabigatran: Review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol 2011; 7: 281-287
6. Alikhan R, Rayment R, Keeling D et al. The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran. Emerg Med J 2014; 31: 163-168. Epub 2013 Feb 22
7. McLellan AJ, Schlaich MP. Dabigatran elimination: Is haemodialysis effective? Thromb Haemost 2013; 109: 580-581
8. Stangier J, Rathgen K, Stähle H et al. Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: An open-label, parallel-group, single-centre study. Clin Pharmacokinet 2010; 49: 259-268
9. Khadzhynov D, Wagner F, Formella S et al. Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease. Thromb Haemost 2013; 109: 596-605
10. Warkentin TE, Margetts P, Connolly SJ et al. Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran- associated postcardiac surgery bleeding. Blood 2012; 119: 2172-2174
11. Chang DN, Dager WE, Chin AI. Removal of dabigatran by hemodialysis. Am J Kidney Dis 2013; 61: 487-489
12. Singh T, Maw TT, Henry BL et al. Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: A single center experience. Clin J Am Soc Nephrol 2013; 8: 1533-1539. Epub 2013 May 23
13. Chen BC, Sheth NR, Dadzie KA et al. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose. Am J Kidney Dis 2013; 62: 591-594
14. Esnault P, Gaillard PE, Cotte J et al. Haemodialysis before emergency surgery in a patient treated with dabigatran. Br J Anaesth 2013; 11: 776-777
15. Wanek MR, Horn ET, Elapavaluru S et al. Safe use of hemodialysis for dabigatran removal before cardiac surgery. Ann Pharmacother 2012; 46: E21
16. Bachellerie B, Ruiz S, Conil JM et al. Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery. Ann Fr Anesth Reanim 2013; 33: 44-46
17. Chiew AL, Khamoudes D, Chan B. Use of continuous venovenous haemodiafiltration therapy in dabigatran overdose. Clin Toxicol (Phila) 2014; 52: 283-287
18. Lavergne V, Nolin TD, Hoffman RS et al. The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: Guideline methodology. Clin Toxicol (Phila) 2012; 50: 403-413